Dianthus Therapeutics (DNTH) Current Assets (2017 - 2025)
Historic Current Assets for Dianthus Therapeutics (DNTH) over the last 8 years, with Q3 2025 value amounting to $413.8 million.
- Dianthus Therapeutics' Current Assets rose 4394.46% to $413.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $413.8 million, marking a year-over-year increase of 4394.46%. This contributed to the annual value of $280.9 million for FY2024, which is 5829.95% up from last year.
- Latest data reveals that Dianthus Therapeutics reported Current Assets of $413.8 million as of Q3 2025, which was up 4394.46% from $263.6 million recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Current Assets ranged from a high of $413.8 million in Q3 2025 and a low of $78.6 million during Q2 2023
- For the 4-year period, Dianthus Therapeutics' Current Assets averaged around $220.7 million, with its median value being $191.5 million (2023).
- As far as peak fluctuations go, Dianthus Therapeutics' Current Assets crashed by 4792.72% in 2023, and later soared by 36502.58% in 2024.
- Over the past 4 years, Dianthus Therapeutics' Current Assets (Quarter) stood at $82.0 million in 2022, then skyrocketed by 116.32% to $177.5 million in 2023, then surged by 58.3% to $280.9 million in 2024, then surged by 47.32% to $413.8 million in 2025.
- Its last three reported values are $413.8 million in Q3 2025, $263.6 million for Q2 2025, and $271.0 million during Q1 2025.